Skip to main content
Have a personal or library account? Click to login
Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which Is the Best aPTT Sampling Site? Cover

Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which Is the Best aPTT Sampling Site?

Open Access
|Aug 2020

Figures & Tables

Table 1

Protocol for bolus and dose adjustment when using UFH on CRRT

Modified unfractionated weight-based heparin nomogram

Target: aPTT x2 Initial Dose (Bolus) 50 UI/Kg * Maintenance 10 - 15 UI/Kg/H

Plasma aPTT foundContinuous rate actionBolusCheck time
Plasma aPTT <35 sec+ 4 UI/Kg/hRebolus 50 UI/KgaPTT afte (3h)
Plasma aPTT 35 - 45 sec+ 2 UI/Kg/hRebolus 20 UI/KgaPTT after (3h)
Plasma aPTT 46 - 60 sec+ 2 UI/Kg/h-aPTT after (3h)
Plasma aPTT 60 - 70 sec--aPTT after (4h)
Plasma aPTT 71 - 90 sec- 2 UI/Kg/h-aPTT after (3h)
Plasma aPTT > 90 sec- 3 UI/Kg/hStop Cont. inf 60 minaPTT after (2h)

[i] First aPTT (4 h) after the initial bolus

* If BW > IBW x 1.3, then use ABW to estimate initial heparin bolus

BW (Body Weight), IBW (Ideal Body Weight), ABW (Adjusted Body Weight)

Fig. 1

Correlation aPTT plots reported to CVC sampling site

Table 2

Correlations and Descriptive Statistics (N = 84) - aPTT values for CVC, Access, Postfilter and Artery

Variables1234
1CVC (sec.)-0.72 (r)0.69 (r)0.46 (r)
2Access (sec.)0.72 (r)-0.62 (r)0.43 (r)
3Postfilter (sec.)0.69 (r)0.62 (r)-0.47 (r)
4Artery (sec.)0.46 (r)0.43 (r)0.47 (r)-

[i] aPTT values: 1 (CVC)= heparin free central venous nondialysis catheter; 2 (Access) = circuit access line; 3 (Postfilter) = circuit return line; 4 (Artery) = arterial line with heparinized solution.

r - correlation coefficient (r). Coefficients printed in bold are significant (p < 0.05).

Table 3

Correlations and Descriptive Statistics depending on artery age

aPTT values for patients with Artery younger than 3 days ---- (n=45)

Variables (sec.)1234
1CVC-0.80 (r)0.71 (r)0.75 (r)
2Access0.80 (r)-0.62 (r)0.67(r)
3Postfilter0.71 (r)0.62 (r)-0.57(r)
4Artery0.75 (r)0.67 (r)0.57 (r)
aPTT values for patients with Artery age between 4 to 6 days---- (n=39)
Variables (sec.)5678
5CVC-0.60 (r)0.64 (r)0.23 (r)
6Access0.60 (r)-0.61 (r)0.35 (r)
7Postfilter0.64 (r)0.61(r)-0.45 (r)
8Artery0.23 (r)0.39 (r)0.45 (r)

[i] aPTT values: Samples from patients with young artery 1-(CVC) = heparin free central venous nondialysis catheter; 2- (Access) = circuit access line; 3-(Postfilter) = circuit return line; 4-(Artery) = arterial line with heparinized solution. Sites aPTT values from patients with old Artery 5-(CVC), 6- (Access), 7-(Postfilter), 8-(Artery). r - correlation coefficient (r). Coefficients printed in bold are significant (p < 0.05).

Table 4

Comparison of CVC, Access, Postfilter and Artery aPTT values

Section AAll patients group (84)Mean (SD)p value
Access (sec.)73 (±20)p = 0.74
Posftilter (sec.)92 (±19)p < 0.0175 (±18)
Artery (sec.)82 (±18)p < 0.01
Section BYoung Artery group (45)Mean (SD)p valueCVC (sec.)
Access (sec.)75 (±17)p = 0.74
Posftilter (sec.)91 (±19)p < 0.0174 (±18)
Artery (sec.)76 (±20)p = 0.63
Section COld Artery group (39)Mean (SD)p valueCVC (sec.)
Access (sec.)63 (±16)p = 0.46
Posftilter (sec.)86 (±16)p < 0.0166 (±18)
Artery (sec.)85 (±14)p < 0.01

[i] aPTT mean (SD) values expressed in seconds compared to CVC sampling site. Section A - All 84 patients; Section B - Young artery group (patients that at assessment time had indwelling arterial line not older than three days); Section C - Patients group with older artery line. Data printed in bold had statistical significance (p < 0.05)

DOI: https://doi.org/10.2478/jccm-2020-0024 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 159 - 166
Submitted on: Feb 25, 2020
Accepted on: Jun 26, 2020
Published on: Aug 11, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Florin Ioan Anton, Paul Adrian Rus, Natalia Hagau, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.